TheraVet S.A.
PAR: ALVET.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gaetan Terrasse
- Employees
- 5
- Headquarters
- Charleroi, Belgium
- IPO year
- 2021
- Market cap
- €10.0M
- Website
- https://www.thera.vet/en
Loading ALVET…
Loading profile data…Frequently asked questions about ALVET
What does TheraVet S.A. (ALVET.PA) do?
TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegratio...
Where does ALVET.PA trade?
TheraVet S.A. (ALVET.PA) trades on the Euronext Paris.
What sector is ALVET.PA in?
TheraVet S.A. (ALVET.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TheraVet S.A.?
Gaetan Terrasse is the chief executive officer of TheraVet S.A. (ALVET.PA).
Where is TheraVet S.A. headquartered?
TheraVet S.A. is headquartered in Belgium.
Does ALVET.PA pay a dividend?
TheraVet S.A. (ALVET.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALVET.PA go public?
TheraVet S.A. (ALVET.PA) completed its initial public offering in 2021.